Rain Oncology Inc
Change company Symbol lookup
Select an option...
RAIN Rain Oncology Inc
ARIZU Arisz Acquisition Corp
OSH Oak Street Health Inc
LESL Leslie's Inc
AAPL Apple Inc
BYM BlackRock Municipal Income Quality Trust
DLA Delta Apparel Inc
PEG Public Service Enterprise Group Inc
WBD Warner Bros Discovery Inc
ERO Ero Copper Corp
Go

Health Care : Pharmaceuticals |
Company profile

Rain Oncology Inc., formerly Rain Therapeutics Inc., is a late-stage precision oncology company. The Company is focused on developing therapies that target oncogenic drivers to genetically select patients. The Company’s product candidates include milademetan and RAD52. Its milademetan is an oral small molecule, an inhibitor of mouse double minute 2 (MDM2) is being developed in patients with wildtype tumor protein 53 (p53) cancers that are also exhibiting MDM2 dependence. MDM2 dependence may be occurring either through MDM2 gene amplification, protein overexpression, loss of an MDM2 regulator, or other mechanisms. RAD52 is focused on the DNA Damage Response (DDR) pathway. RAD52 represents a strategy for patients that may exhibit homologous recombination deficiencies (HRD+), or a loss of function, of several pathway constituents, including BRCA1/2, PALB2, or several others in tumor types frequently characterized by these deficiencies.

Closing Price
$8.46
Day's Change
-0.04 (-0.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
8.86
Day's Low
8.27
Volume
(Light)
Volume:
88,767

10-day average volume:
221,483
88,767

Display:

Providers:

UpdateCancel
6 providers
March 21, 2023
March 09, 2023
March 07, 2023
February 23, 2023
February 14, 2023
Thinking about buying stock in Palantir Technologies, Fusion Pharmaceuticals, Rain Oncology, Iveda Solutions, or Opendoor Technologies?

, NY — InvestorsObserverissues critical PriceWatch Alerts for PLTR, FUSN, RAIN, IVDA, and OPEN. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view...(PR Newswire)

February 09, 2023
January 31, 2023
January 23, 2023
December 29, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.